NASDAQ$LUNG

Pulmonx Corporation · Q1 2023 earnings

Q1 2023 earnings · · Investor relations

Briefing

Pulmonx reported first quarter results, demonstrating revenue growth and sustained momentum.

Pulmonx reported a 35% increase in worldwide revenue to $14.5 million for the first quarter of 2023, with U.S. revenue increasing by 55%. The company's gross margin was 73%.

  • Worldwide revenue increased by 35% to $14.5 million.
  • U.S. revenue increased by 55%.
  • Gross margin was 73%.
  • 15 new U.S. treatment centers for Zephyr Valves were added.

Headline financials

Total Revenue

$14.5M

Previous: $10.8M+34.8%
EPS (adj)

-$0.42

Previous: -$0.43+2.3%
Gross Margin

73.0%

No prior period
Capital Expenditures

-$61K

Previous: -$564K+89.2%
Free Cash Flow

-$15.9M

Previous: -$16.4M+2.9%
Net Income

-$15.9M

Previous: -$15.8M-0.2%
Operating Income

-$16.4M

Previous: -$15.7M-4.7%
Gross Profit

$10.6M

Previous: $8.11M+30.6%
Cash & Equivalents

$110M

Previous: $129M-14.5%
Total Assets

$201M

Previous: $223M-9.7%
Stock-Based Comp

$4.64M

Previous: $3.51M+32.0%

Revenue & EPS history

Pulmonx · Revenue · Quarterly

$14.5M

Q1 2023+34.8%vs Q1 2022
Beat estimate in 12 of 14 quarters(86%)
ActualEstimate

Forward guidance

Pulmonx expects full year 2023 revenue to be in the range of $63 million to $65 million and gross margin to be in the range of 73% to 74%. Total operating expenses are expected to be in the range of $112 million to $114 million.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2023

Historical avgQ1 2023

-3.4%

Avg return

Earnings day

-4.1%

Avg return

5 days after

-5.3%

Avg return

30 days after

42%

10 / 24 earnings

Positive

+32.2%

Q4 2024

Best reaction

-64.7%

Q3 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-1.5%-6.7%+12.6%
Q4 2025+0.6%-6.1%-28.2%
Q3 2025-18.9%-28.6%+29.1%
Q1 2025-21.9%-28.8%-29.6%
Q4 2024+32.2%+30.7%+17.0%
Q3 2024-7.7%+5.2%-4.7%
Q2 2024-8.1%-15.4%+3.7%
Q1 2024+23.3%+21.9%-4.7%
Q4 2023-17.7%-27.9%-36.1%
Q3 2023+6.9%+20.7%+34.2%
Q2 2023-4.1%-8.0%-26.0%
Q1 2023+1.1%-0.2%-1.5%
Q4 2022+20.8%+26.0%+27.1%
Q3 2022-64.7%-61.1%-52.3%
Q2 2022+9.2%+19.9%+5.7%
Q1 2022+0.6%-23.6%-23.9%
Q4 2021-6.9%-2.5%-12.5%
Q3 2021+7.1%+12.6%-23.7%
Q2 2020-7.6%-10.9%-1.6%
Q2 2021+0.1%+6.0%+3.3%
Q1 2020-5.8%-5.3%+9.9%
Q1 2021-8.7%-9.6%-10.3%
Q4 2020-4.1%-3.4%-20.2%
Q3 2020-4.9%-3.4%+5.6%
Q4 2019
Q3 2019
Q2 2019
Q1 2019

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro